SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of BridgeBio Pharma, Inc. (NASDAQ: BBIO)
1. Purcell & Lefkowitz LLP investigates BBIO for potential fiduciary breaches. 2. Shareholders may have been affected by recent corporate actions. 3. Investigation aims to protect shareholder interests against misconduct.